Navigation Links
Microbes, Inc. Extends Warrant Tender Offer
Date:8/7/2008

NEW YORK, Aug. 7 /PRNewswire/ -- Microbes, Inc. today announced that it has extended its current offer to purchase any and all of its outstanding Class B Common Stock Purchase Warrants, Class 1 and Class B Common Stock Purchase Warrants, Class 2 until 12:00 midnight, New York City time, on Friday, August 15, 2008. The offer was scheduled to expire at 12:00 midnight, New York City time, on August 7, 2008.

The extension will provide Warrant holders additional time to determine whether to tender their Warrants in response to the Company's tender offer. Microbes is offering holders of the Warrants $0.25 per share in cash, without interest, for each share of Class B Common Stock, $.001 par value, for which a Warrant may be exercised and for which the Warrant remains unexercised at the time of acceptance in the tender offer.

The tender offer is being made solely by the Offer to Purchase and the related Letter of Transmittal. Holders of Warrants are urged to read the Offer to Purchase and the related Letter of Transmittal, as well as any amendments or supplements thereto when they become available, because they contain important information.

Microbes' business involves the manufacture and sale of microbial products to increase the yield of oilfields and food crops. Microbes is headquartered in The Woodlands, Texas.


'/>"/>
SOURCE Microbes, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Congress Extends 2007 Reimbursement Rates for Radioimmunotherapies for 18 Months
2. Unilever Extends Their GeneGo MetaCore License
3. Rentschler Biotechnologie Extends Capacities for Mammalian Cell Culture Manufacturing
4. Symmetry Medical Extends 10-K Filing Beyond April 14, 2008 Target
5. Gerson Lehrman Group Extends Partnership With BIO to Provide Scientific Expertise for the First Annual BIO National Venture Conference
6. Ingenuity Systems Extends Enterprise-Level Software Agreement With GlaxoSmithKline
7. Actavis Receives Approval for Irinotecan Hydrochloride Injection; Extends US Portfolio with First Injectable Product
8. Evotec Extends Ongoing Collaboration With CHDI Worth up to US$ 37 Million
9. Netsmart Technologies Extends Relationship with Manatee Glens for Enterprise Behavioral Health Software Solutions
10. GSK Extends GeneGo License and Adds New Products
11. Roche Extends Tender Offer for Ventana
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/22/2017)... , March 22, 2017 MarketNewsUpdates.com News ... ... conditions are being pressured as of late due to the ... pain management has a dramatic impact on patient,s quality of ... development activities for identifying new forms of opioid formulations that ...
(Date:3/22/2017)... 22, 2017   VWR (NASDAQ: ... product and service solutions to laboratory and ... acquired EPL Archives, Inc., an international biorepository ... entire regulated product research, development and commercialization ... and ancillary services. EPL Archives is widely ...
(Date:3/22/2017)... ... March 21, 2017 , ... Proper glycosylation is critical for ... increase and/or decrease in antibody-dependent cellular cytotoxicity or complement-dependent cytotoxicity, there is a ... , To meet this demand, the team at SCIEX has developed a ...
(Date:3/22/2017)... ... March 21, 2017 , ... The Conference Forum has ... Summit) to be held on May 10-11, 2017, at the Colonnade Hotel in Boston, ... for Chief Medical Officer peer-to-peer learning, benchmarking and support. , “The Chief Medical Officer ...
Breaking Biology Technology:
(Date:3/6/2017)... 6, 2017 Mintigo , the ... announced Predictive Sales Coach TM , its new ... intelligence into Salesforce. This unique AI application will ... organizations with deep knowledge of their customers and ... engagement. Predictive Sales Coach extends Mintigo,s existing customer ...
(Date:3/2/2017)... March 2, 2017 Australian stem cell and ... CYP), has signed an agreement with the Monash Lung ... Biomedicine Discovery Institute and Department of Pharmacology at Monash ... further preclinical study to support the use of Cymerus™ ... Asthma is a chronic, long term ...
(Date:2/28/2017)... , Spanien, 27. Februar 2017  EyeLock LLC, ein ... wird seine erstklassige biometrische Lösung zur Iris-Erkennung ... mit X16 LTE auf dem Mobile World ... am Qualcomm-Stand in Halle 3, Stand 3E10, ... die Sicherheitsplattform Qualcomm Haven™ – eine Kombination ...
Breaking Biology News(10 mins):